The PT-141 peptide is FDA approved as the injectable brand-name medication Vyleesi (bremelanotide), which is indicated for premenopausal women who have hypoactive sexual desire disorder not caused by a medical or mental health condition, relationship problems, or medication side effects
Our product line includes the GHK-Cu copper tripeptide complex in both 50mg and 100mg vials, enabling flexible experimental design across a wide range of laboratory applications
Yes, when given under medical supervision with proper screening
If youre looking for a non-invasive way to boost your energy and feel better, these shots are a great option
The "One Hit Wonder" shot
Most patients begin noticing reduced inflammation and improved mobility within 12 weeks, with more significant healing and recovery benefits developing over 36 weeks, depending on the condition being treated